CAS 366789-02-8

General Information

In its finished dose formulation, Rivaroxaban is an oral anti-clotting substance (anticoagulant drug) which is used in the following instances: to prevent venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), in patients undergoing hip or knee replacement surgery; to prevent stroke and systemic embolism (in patients with atrial fibrillation); to treat DVT and PE and to reduce the risk of recurrent DVT and PE.

About the API

Systematic name 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide.
Trade name(s) Xarelto
Technology Synthetic
Molecular Formula C19H18CIN3O5S
Molecular Weight 435.89 g/mol
Physical properties White to yellowish power
Therapeutic category Coagulation Inhibitors
Available formulations Oral Solid
Regulations CADIFA Flag CADIFA CEP Flag CEP EU DMF Flag EU DMF Korea DMF Flag Korea DMF US DMF Flag US DMF